X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (61) 61
index medicus (45) 45
humans (42) 42
cancer (29) 29
chemotherapy (27) 27
female (26) 26
colorectal cancer (25) 25
male (25) 25
middle aged (25) 25
aged (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
oxaliplatin (19) 19
adult (18) 18
cetuximab (18) 18
colorectal neoplasms - drug therapy (18) 18
leucovorin (16) 16
treatment outcome (16) 16
care and treatment (15) 15
hematology, oncology and palliative medicine (15) 15
metastasis (15) 15
research (15) 15
1st-line treatment (14) 14
aged, 80 and over (14) 14
survival (14) 14
camptothecin - analogs & derivatives (12) 12
fluorouracil - therapeutic use (12) 12
colorectal neoplasms - pathology (11) 11
fluorouracil (11) 11
fluorouracil - administration & dosage (11) 11
drug therapy (10) 10
leucovorin - therapeutic use (10) 10
mutation (10) 10
organoplatinum compounds - therapeutic use (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
disease-free survival (9) 9
irinotecan (9) 9
antibodies, monoclonal, humanized (8) 8
antineoplastic agents - therapeutic use (8) 8
camptothecin - therapeutic use (8) 8
leucovorin - administration & dosage (8) 8
liver neoplasms - secondary (8) 8
surgery (8) 8
therapy (8) 8
bevacizumab (7) 7
cancer research (7) 7
cancer therapies (7) 7
capecitabine (7) 7
colorectal-cancer (7) 7
life sciences (7) 7
metastatic colorectal-cancer (7) 7
organoplatinum compounds - administration & dosage (7) 7
survival analysis (7) 7
adjuvant chemotherapy (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
cell lung-cancer (6) 6
chemotherapy, adjuvant (6) 6
colorectal neoplasms - genetics (6) 6
diagnosis (6) 6
fluorouracil - adverse effects (6) 6
leucovorin - adverse effects (6) 6
metastases (6) 6
metastatic colorectal cancer (6) 6
neoplasm staging (6) 6
oncology, experimental (6) 6
prognosis (6) 6
adjuvant treatment (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
camptothecin - adverse effects (5) 5
cancer patients (5) 5
carcinoma (5) 5
colon-cancer (5) 5
continuous-infusion (5) 5
further section · weitere sektionen (5) 5
immunohistochemistry (5) 5
liver metastases (5) 5
liver neoplasms - drug therapy (5) 5
neoplasm metastasis (5) 5
radiotherapy (5) 5
review (5) 5
adenocarcinoma (4) 4
adenocarcinoma - drug therapy (4) 4
analysis (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal - therapeutic use (4) 4
camptothecin - administration & dosage (4) 4
clinical trials (4) 4
colon cancer (4) 4
colorectal neoplasms - mortality (4) 4
combination (4) 4
combined modality therapy (4) 4
cup (4) 4
deoxycytidine - analogs & derivatives (4) 4
expression (4) 4
further section (4) 4
health aspects (4) 4
kaplan-meier estimate (4) 4
kras (4) 4
liver neoplasms - surgery (4) 4
medicine & public health (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 38 - 47
Summary Background Neoadjuvant chemotherapy for unresectable colorectal liver metastases can downsize tumours for curative resection. We assessed the... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | BEVACIZUMAB | OXALIPLATIN | FLUOROURACIL | HEPATIC RESECTION | CANCER | CARCINOMA | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Tomography, Spiral Computed | Liver Neoplasms - chemistry | Hepatectomy | Antibodies, Monoclonal, Humanized | Fluorouracil - therapeutic use | Austria | Leucovorin - adverse effects | Fluorouracil - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Cetuximab | Liver Neoplasms - secondary | Odds Ratio | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Liver Neoplasms - genetics | Risk Assessment | Liver Neoplasms - drug therapy | Linear Models | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Magnetic Resonance Imaging | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Germany | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 979 - 989
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 862 - 873
Summary Background Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | ADJUVANT TREATMENT | NSABP C-07 | KRAS | COMBINATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Diarrhea - chemically induced | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Infusions, Intravenous - adverse effects | Adult | Female | Leucovorin - therapeutic use | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Cetuximab | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Exons - genetics | Proto-Oncogene Proteins - genetics | Adenocarcinoma - drug therapy | Mucositis - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Intention to Treat Analysis | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Prevention | Care and treatment | Chemotherapy | Colon cancer | Hospitals | Leucovorin | Product development | Cancer | Index Medicus | Life Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 14, pp. 1408 - 1417
Journal Article
Der Onkologe, ISSN 0947-8965, 12/2017, Volume 23, Issue 12, pp. 1006 - 1010
Die Therapie von Patienten mit einem CUP-Syndrom (CUP:„cancer of unknown primary“) entsprechend dem Ursprungsgewebe ist Teil der Standardbehandlung, wenn sich... 
CUP syndrome | Immunohistochemistry | Medicine & Public Health | CUP-Syndrom | Immunhistologie | Oncology | Tumor | Systemic treatment | Review | Systemische Therapie
Journal Article
Der Onkologe, ISSN 0947-8965, 12/2017, Volume 23, Issue 12
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00761-017-0308-5 Die... 
Immunohistochemistry | Analysis | Methylation | Gene expression | Drug approval
Journal Article
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 10/2013, Volume 138, Issue 41, pp. 2098 - 2103
Zusammenfassung Die Behandlung von Patienten mit kolorektalen Lebermetastasen hat sich durch die Möglichkeiten der Resektion und der zunehmend effektiveren... 
Übersicht | Review article | multidisciplinary therapy | colorectal cancer | chemotherapy | neoadjuvant therapy | liver metastases
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 679 - 687
Journal Article